dockets: FDA-2026-P-4567

Regulatory dockets from Regulations.gov — containers for related documents and comments in a rulemaking proceeding.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id title docket_type last_modified object_id rin dkabstract category subtype keywords program short_title effective_date organization attrs_raw attr_source
FDA-2026-P-4567 FDA Requests that the FDA determine whether the Reference Listed Drug (RLD) LASIX ORAL SOLUTION, 10 mg/mL; New Drug Application (NDA) 017688 of SANOFI AVENTIS US LLC has been voluntarily withdrawn from sale for safety or efficacy reasons. Nonrulemaking 2026-04-24T18:54:10Z 0b000064b92a89c2         ["CDER", "Citizen Petition", "Lachman Consultant Services Inc", "determine whether the Reference Listed Drug", "LASIX ORAL SOLUTION", "10 mg mL", "New Drug Application 017688", "of SANOFI AVENTIS US LLC", "has been voluntarily withdrawn", "from sale for safety or efficacy reasons", "OPEN"] CDER Requests that the FDA determine whether the Reference Listed Drug (RLD) LASIX ORAL SOLUTION, 10 mg/mL; New Drug Application (NDA) 017688 of SANOFI AVENTIS US LLC has been voluntarily withdrawn.     {"displayProperties": [{"name": "generic", "label": "Docket Item Code", "tooltip": "An agency specific code that identifies the type of document that established the docket (regulatory action)."}, {"name": "program", "label": "Center", "tooltip": "The agency specific program associated with the docket (regulatory action); equivalents: Docket Item Code, Location."}, {"name": "field2", "label": "Docket Status", "tooltip": "Used to Identity that a Docket's Status is Open or Closed"}, {"name": "shortTitle", "label": "Short Title", "tooltip": "A combination of letters and or numbers assigned to an agency's regulatory action for purposes of brevity."}], "keywords": ["CDER", "Citizen Petition", "Lachman Consultant Services Inc", "determine whether the Reference Listed Drug", "LASIX ORAL SOLUTION", "10 mg mL", "New Drug Application 017688", "of SANOFI AVENTIS US LLC", "has been voluntarily withdrawn", "from sale for safety or efficacy reasons", "OPEN"], "modifyDate": "2026-04-24T18:54:10Z", "dkAbstract": null, "agencyId": "FDA", "program": "CDER", "shortTitle": "Requests that the FDA determine whether the Reference Listed Drug (RLD) LASIX ORAL SOLUTION, 10 mg/mL; New Drug Application (NDA) 017688 of SANOFI AVENTIS US LLC has been voluntarily withdrawn.", "subType2": null, "title": "Requests that the FDA determine whether the Reference Listed Drug (RLD) LASIX ORAL SOLUTION, 10 mg/mL; New Drug Application (NDA) 017688 of SANOFI AVENTIS US LLC has been voluntarily withdrawn from sale for safety or efficacy reasons.", "generic": "P", "field1": null, "docketType": "Nonrulemaking", "petitionNbr": null, "rin": null, "organization": null, "legacyId": null, "subType": null, "category": null, "field2": "OPEN", "effectiveDate": null, "objectId": "0b000064b92a89c2"} single_get

Links from other tables